Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882283 · ClinicalTrials.gov registry record · NA
Effects of Black Tea Intake on Serum Lipids
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT01882283 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 57 participants.
The verdict
NCT01882283, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
A diet-controlled clinical trial which attempts to provide estimates of the effect of black tea consumption on serum lipids under tightly controlled conditions, including a controlled diet. Mildly hypercholesterolemic individuals (total cholesterol levels between 4.9 and 6.7 mmol/L, 190 and 260 mg/dl), non-smoking, chronic disease-free individuals were enrolled in a 15-week, double blind, randomized crossover trial, during which they consumed a controlled low-flavonoid diet plus 5 cups of black tea or a tea-like placebo over two 4-week treatment periods.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Tea Treatment Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2002-04 |
| Est. Completion | 2004-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01882283
The ClinicalTrials.gov registry entry for NCT01882283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01882283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01882283 about?
NCT01882283 is a clinical study titled "Effects of Black Tea Intake on Serum Lipids". A diet-controlled clinical trial which attempts to provide estimates of the effect of black tea consumption on serum lipids under tightly controlled conditions, including a controlled diet. Mildly hypercholesterolemic individuals (total cholesterol levels between 4.9 and 6.7 mmol/L, 190 and 260 mg/d...
What is the current status of trial NCT01882283?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2002-04. Estimated completion is 2004-04.
What interventions are being tested in trial NCT01882283?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Tea Treatment Group (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01882283?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.